Liver-targeting drug delivered via nanogel carrier reverses obesity, lowers cholesterol in mice

A University of Massachusetts Amherst biomedical engineer has used a nanogel-based carrier designed in his lab to deliver a drug exclusively to the liver of obese mice, effectively reversing their diet-induced disease.